IFNG and neoplasm: While T cells with Vγ9Vδ2 TCR (γδ T cells) constitute a small (2–5%) fraction of total T cells, they exhibit potent antitumor activity via release of inflammatory cytokines including (1) IFN-γ which inhibits tumor growth and (2) granzymes and perforin, which directly kill tumors [6].